Does TECLISTAMAB Cause Plasma cell myeloma? 100 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 100 reports of Plasma cell myeloma have been filed in association with TECLISTAMAB (TECVAYLI). This represents 8.2% of all adverse event reports for TECLISTAMAB.
100
Reports of Plasma cell myeloma with TECLISTAMAB
8.2%
of all TECLISTAMAB reports
51
Deaths
22
Hospitalizations
How Dangerous Is Plasma cell myeloma From TECLISTAMAB?
Of the 100 reports, 51 (51.0%) resulted in death, 22 (22.0%) required hospitalization, and 7 (7.0%) were considered life-threatening.
Is Plasma cell myeloma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB. However, 100 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB Cause?
Cytokine release syndrome (257)
Pneumonia (101)
Immune effector cell-associated neurotoxicity syndrome (99)
Pyrexia (86)
Covid-19 (82)
Infection (58)
Drug ineffective (52)
Neutropenia (48)
Sepsis (48)
Febrile neutropenia (44)
What Other Drugs Cause Plasma cell myeloma?
LENALIDOMIDE (14,191)
DEXAMETHASONE (9,207)
POMALIDOMIDE (7,023)
BORTEZOMIB (6,683)
IXAZOMIB (3,249)
DARATUMUMAB (2,980)
CARFILZOMIB (2,238)
CYCLOPHOSPHAMIDE (2,058)
THALIDOMIDE (1,652)
SELINEXOR (1,046)
Which TECLISTAMAB Alternatives Have Lower Plasma cell myeloma Risk?
TECLISTAMAB vs TECLISTAMAB-CQYV
TECLISTAMAB vs TEDIZOLID
TECLISTAMAB vs TEDUGLUTIDE
TECLISTAMAB vs TEDUGLUTIDE\WATER
TECLISTAMAB vs TEGAFUR